Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAPTYSBIO, INC Director's Dealing 2021

Apr 12, 2021

32596_dirs_2021-04-12_86907341-1220-43c0-8ad8-7778e85bddec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2021-04-08

Reporting Person: NODELMAN OLEG (Director, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7151624 Indirect

Footnotes

F1: Mr. Nodelman is the manager and controlling owner of EcoR1 Capital, LLC, which is the investment adviser and general partner of private funds. The funds hold these securities directly for the benefit of their investors. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1 Capital, LLC. Mr. Nodelman disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.